Pfizer maintains dividend amid growth plans; tax-free muni bonds and REITs also discussed.

Pfizer is navigating a transitional phase aiming for growth by 2029, maintaining its dividend payout to support financial stability despite patent losses and reduced COVID revenues. The company’s dividend payout ratio aligns with management’s long-term goal, reflecting a cautious but steady approach. The article also explores tax-free high-yield municipal bond ETFs, noting their federal tax advantages but potential state tax and alternative minimum tax implications. Additionally, mortgage REITs like AGNC and NLY are viewed skeptically, while stocks like Gladstone Land and the Virtus InfraCap Preferred Stock ETF are added to a watchlist for their unique income strategies and yields.